SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of AmeriSourceBergen

12

AmerisourceBergen

ABC

AmerisourceBergen is the second-largest distributor of pharmaceuticals in the U.S. As such, it’s subject to many of the same forces affecting McKesson, its top competitor. Generic drug price deflation and fewer expected generic-drug launches will put pressure on overall industry profits this year and next. AmerisourceBergen has been working to counter those effects by entering new markets through strategic acquisitions. This includes getting into animal health distribution with MWI Veterinary Supply, compounding with PharMEDium, and clinical trial logistics with World Courier. AmerisourceBergen also could face a windfall of new revenue in coming years after its partner Walgreens absorbs Rite Aid and its more than 4,500 pharmacists.

CEO

Steven H. Collis

Sector

Health Care

Industry

Wholesalers: Health Care

HQ Location

Chesterbrook, PA

Years on Fortune 500 List

22

Employees

17,000

AmerisourceBergen is also featured in these fortune lists
Figures are for fiscal year ended Sept. 30, 2015.
Key Financials (last fiscal year)
$ millions% change
Revenues ($M)$135,96213.7%
Profits ($M)$-135-148.8%
Assets ($M)$27,736
Total Stockholder Equity ($M)$634
Market Value — as of March 31, 2016 ($M)$19,511
Profit Ratios
Profit as % of Revenues-0.1%
Profits as % of Assets-0.5%
Profits as % of Stockholder Equity-21.3%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)-0.62
EPS % Change (from 2014)-153.0%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-
Total Return
Total Return to Investors (2015)16.4%
Total Return to Investors (5 year, annualized)26.6%
Total Return to Investors (10 year, annualized)19.1%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about AmerisourceBergen

These Pharma Stocks Plunged on Reports of Pending Price Collusion Charges

And the lawmakers who called for the probe now want it expanded to diabetes drugs.

Read More →
The Biggest Health Care Companies in the Fortune 500

This year's list includes insurers, drug wholesalers, and some household names.

Read More →
Pharma Packager PCI Sells for More Than $1 Billion

Deal sets the stage for even more M&A activity in outsourced pharma services sector.

Read More →
How to Create a Great Workplace in Health Care

The 2016 Best Workplaces in Health Care offer camaraderie, support, and kitten cards.

Read More →